Enanta Pharmaceuticals (ENTA) PT Lowered to $44 at SVB Leerink
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $13.15 -2.16%
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
SVB Leerink analyst Roanna Ruiz lowered the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $44.00 (from $58.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Enanta Pharma (ENTA) Misses Q3 EPS by 17c
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
